DO NOT expect this much firework from the NICE JUIDICIAL REVIEW.
Just have a look at the Alzheimer Judicial Review and you will get my point. Too much money power and egomaniacs involved and careers at stake.
And no one cares about patients who are crippled or bedbound as they do not see us anyway.......
And the RSS Feed for my Blog lights up on Internet Explorer on the top right.
I DO NOT know how to put it elsewhere on my BLOG.
Anybody who can help ????
Friday, November 21, 2008
CBT: Crash Bang Therapy ...
Labels:
CBT,
CDC,
CFS/ME,
CHRONIC DISEASE,
comment,
Cool Blogging Therapy,
Coping,
DIAGNOSING,
GLT,
GOBSART,
GUIDELINES,
Health,
LIFE,
ME,
NICE,
stress
Subscribe to:
Post Comments (Atom)
1 comment:
Hi Dr Speedy, I thought this might interest you as it ties in with Dr Wright's work here in the UK & Dr Lerner's work in the US. The GOBSART's at the Medical Research Council have repeatedly refused Dr Kerr's research funding. Psychiatrist Prof White currently has about £4 million from them for his ridiculous PACE trials.
"Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a
multisystem disease, the pathogenesis of which remains undetermined.
Following two microarray studies, we reported the differential
expression of 88 human genes in patients with CFS; 85 of these genes
were upregulated and 3 were downregulated. The top functional
categories of these 88 genes were hematologic disease and function,
immunologic disease and function, cancer, cell death, immune response,
and infection. Clustering of quantitative polymerase chain reaction
data from CFS/ME patients revealed seven subtypes with distinct
differences in Short Form (SF)-36 scores, clinical phenotypes, and
severity. Gene signatures in each subtype implicate five human genes
as possible targets for specific therapy. Development of a diagnostic
test for subtype status is now a priority. The possibility that these
subtypes represent individual host responses to particular microbial
infections is being investigated and may provide another route to
specific therapies for CFS patients."
Gene Profiling of Patients with Chronic Fatigue Syndrome/Myalgic
Encephalomyelitis [abstract]
Jonathan R. Kerr, MB BCh, MD, PhD, FRCPath
Corresponding author:
Jonathan R. Kerr, MB BCh, MD, PhD, FRCPath
St. George's University of London, Cranmer Terrace, London SW17 0RE,
United Kingdom.
Post a Comment